Pre-order Enquiry
Request Free Sample
Global and China Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
SKU ID : QYR-16374137 | Publishing Date : 04-Sep-2020 | No. of pages : 92
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and China Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2020 VS 2026
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2015-2026)
2.2 Global Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Regions
2.2.1 Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Market Size
3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2015-2020)
3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2015-2020)
3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue
3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio
3.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2019
3.5 Key Players Monoclonal antibodies (mAbs) Biosimilars Area Served
3.6 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
3.7 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Type (2015-2026)
4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2021-2026)
5 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application (2015-2026)
5.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Application (2015-2020)
5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2026)
6.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)
6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)
6.4 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2026)
7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)
7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)
7.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2026)
8.2 China Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)
8.3 China Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)
8.4 China Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2026)
9.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)
9.3 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)
9.4 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2026)
10.2 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)
10.3 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)
10.4 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Details
11.1.2 Biocon Business Overview
11.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction
11.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020))
11.1.5 Biocon Recent Development
11.2 Celltrion
11.2.1 Celltrion Company Details
11.2.2 Celltrion Business Overview
11.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction
11.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.2.5 Celltrion Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Details
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction
11.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 Hospira
11.4.1 Hospira Company Details
11.4.2 Hospira Business Overview
11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction
11.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.4.5 Hospira Recent Development
11.5 3SBio
11.5.1 3SBio Company Details
11.5.2 3SBio Business Overview
11.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction
11.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.5.5 3SBio Recent Development
11.6 Accord Healthcare
11.6.1 Accord Healthcare Company Details
11.6.2 Accord Healthcare Business Overview
11.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction
11.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.6.5 Accord Healthcare Recent Development
11.7 AET Biotech
11.7.1 AET Biotech Company Details
11.7.2 AET Biotech Business Overview
11.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
11.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.7.5 AET Biotech Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction
11.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.8.5 Allergan Recent Development
11.9 Amega Biotech
11.9.1 Amega Biotech Company Details
11.9.2 Amega Biotech Business Overview
11.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
11.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.9.5 Amega Biotech Recent Development
11.10 Others
11.10.1 Others Company Details
11.10.2 Others Business Overview
11.10.3 Others Monoclonal antibodies (mAbs) Biosimilars Introduction
11.10.4 Others Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
11.10.5 Others Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Erythropoietin (EPO)
Table 4. Key Players of Human Growth Hormone (HGH)
Table 5. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 6. Key Players of Monoclonal Antibody (mAb)
Table 7. Key Players of Insulin
Table 8. Key Players of Interferon (IFN)
Table 9. Key Players of Others
Table 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2015-2020)
Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2021-2026)
Table 16. Monoclonal antibodies (mAbs) Biosimilars Market Market Trends
Table 17. Monoclonal antibodies (mAbs) Biosimilars Market Drivers
Table 18. Monoclonal antibodies (mAbs) Biosimilars Market Challenges
Table 19. Monoclonal antibodies (mAbs) Biosimilars Market Restraints
Table 20. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players (2015-2020)
Table 22. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2019)
Table 23. Global Monoclonal antibodies (mAbs) Biosimilars by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Type (2015-2020)
Table 29. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2021-2026)
Table 30. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2015-2020)
Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2021-2026)
Table 33. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2020)
Table 35. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2020)
Table 37. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2015-2020)
Table 39. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2020)
Table 41. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2020)
Table 43. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2015-2020)
Table 45. China Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020) (US$ Million)
Table 46. China Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2020)
Table 47. China Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020) (US$ Million)
Table 48. China Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2020)
Table 49. China Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (US$ Million) (2015-2020)
Table 50. China Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2015-2020)
Table 51. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2020)
Table 53. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2020)
Table 55. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2015-2020)
Table 57. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2020)
Table 59. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2020)
Table 61. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2015-2020)
Table 63. Biocon Company Details
Table 64. Biocon Business Overview
Table 65. Biocon Product
Table 66. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 67. Biocon Recent Development
Table 68. Celltrion Company Details
Table 69. Celltrion Business Overview
Table 70. Celltrion Product
Table 71. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 72. Celltrion Recent Development
Table 73. Dr. Reddy's Laboratories Company Details
Table 74. Dr. Reddy's Laboratories Business Overview
Table 75. Dr. Reddy's Laboratories Product
Table 76. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 77. Dr. Reddy's Laboratories Recent Development
Table 78. Hospira Company Details
Table 79. Hospira Business Overview
Table 80. Hospira Product
Table 81. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 82. Hospira Recent Development
Table 83. 3SBio Company Details
Table 84. 3SBio Business Overview
Table 85. 3SBio Product
Table 86. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 87. 3SBio Recent Development
Table 88. Accord Healthcare Company Details
Table 89. Accord Healthcare Business Overview
Table 90. Accord Healthcare Product
Table 91. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 92. Accord Healthcare Recent Development
Table 93. AET Biotech Company Details
Table 94. AET Biotech Business Overview
Table 95. AET Biotech Product
Table 96. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 97. AET Biotech Recent Development
Table 98. Allergan Business Overview
Table 99. Allergan Product
Table 100. Allergan Company Details
Table 101. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 102. Allergan Recent Development
Table 103. Amega Biotech Company Details
Table 104. Amega Biotech Business Overview
Table 105. Amega Biotech Product
Table 106. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 107. Amega Biotech Recent Development
Table 108. Others Company Details
Table 109. Others Business Overview
Table 110. Others Product
Table 111. Others Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020) (US$ Million)
Table 112. Others Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2020 VS 2026
Figure 2. Erythropoietin (EPO) Features
Figure 3. Human Growth Hormone (HGH) Features
Figure 4. Granulocyte- Colony Stimulating Factor (G-CSF) Features
Figure 5. Monoclonal Antibody (mAb) Features
Figure 6. Insulin Features
Figure 7. Interferon (IFN) Features
Figure 8. Others Features
Figure 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2020 VS 2026
Figure 10. Anti-Cancer Case Studies
Figure 11. Anti-Inflammatory/Autoimmune Case Studies
Figure 12. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
Figure 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions: 2020 VS 2026
Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2021-2026)
Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2019
Figure 17. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2019
Figure 19. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Biocon Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 47. Celltrion Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 48. Dr. Reddy's Laboratories Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 49. Hospira Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 50. 3SBio Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 51. Accord Healthcare Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 52. AET Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 53. Allergan Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 54. Amega Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 55. Others Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Keyplayers in Global and China Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
BioconCelltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Others
